H.R. 9321, known as the "American Made Pharmaceuticals Act of 2024," proposes the creation of a test program to give preferential treatment to drugs and biologicals manufactured in the United States under Medicare, Medicaid, and CHIP programs. This program, managed by the Secretary of Health...
Simple Explanation
The bill is like a fun test where the U.S. wants to give a special boost to medicines that are made in America, helping them be cheaper or give extra rewards to doctors, but some people worry the rules aren't clear enough about how it's done.